Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Merck & Co. Inc. buy Royal Bank of Canada

Merck & Co. Inc.
Start price
€102.80
30.03.26 / 50%
Target price
€123.30
30.03.27
Performance (%)
27.04%
Price
€130.60
21.08.26
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 27.04%. This prediction currently runs until 30.03.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Merck & Co. Inc. 11.206% 11.206%
iShares Core DAX® -1.283% 4.209%
iShares Nasdaq 100 -3.338% -1.744%
iShares Nikkei 225® -4.286% -1.621%
iShares S&P 500 -2.311% -0.096%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Merck & Co. Inc. diskutieren
Prediction Buy
Perf. (%) 27.04%
Target price 123.299
Change
Ends at 30.03.27

Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Royal Bank of Canada 
0
Report Share
30.03.26

Stopped prediction by Royal_Bank_of_Canada for Merck & Co. Inc.

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€111.06
08.07.26
€124.38
08.07.27
17.59%
21.08.26

Royal Bank of Canada 
08.07.26 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€105.40
25.02.26
€120.47
25.02.27
23.91%
21.08.26

Royal Bank of Canada 
25.02.26 50%